ClinVar Miner

Submissions for variant NM_018238.4(AGK):c.1166_1167dup (p.Tyr390fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002862667 SCV003227703 pathogenic Sengers syndrome; Cataract 38 2024-08-15 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr390Serfs*9) in the AGK gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 33 amino acid(s) of the AGK protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AGK-related conditions. ClinVar contains an entry for this variant (Variation ID: 2021455). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the C-terminus of the AGK protein. Other variant(s) that disrupt this region (p.Tyr390*, Gln405*, Phe406Valfs*4) have been observed in individuals with AGK-related conditions (PMID: 22277967, 22284826, 31303091). This suggests that this may be a clinically significant region of the protein. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.